Market Research Future

Uterine Fibroid Market Is Estimated to Grow at a CAGR over 3.24% by 2022

Uterine Fibroid Market Information by Type (Subserosal Fibroids, Intramural Fibroids), Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound) - Forecast to 2022

 

Pune, Maharashtra -- (SBWIRE) -- 05/16/2017 -- Market Research Future published a Cooked Research Report (CCR) on U.S. Uterine Fibroid Market. The U.S. Uterine Fibroid Market is expected to grow with a CAGR of 3.24% During the period 2016 to 2022

Market Overview:

Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman's uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen.

Uterine fibroids are spreading over U.S. at a steady pace due to its high prevalence in African- American race. The exact cause of uterine fibroids is unknown, however heredity of uterine fibroids, high blood pressure and low levels of vitamin D are some of the major causing factors of uterine fibroids. Based on the market scenario, it has been observed that procedures like hysterectomy and myomectomy are majorly covering the Uterine Fibroid treatment market despite of their side effects, which as a result is showcasing the limited treatment options for UF.

The U.S. Uterine Fibroid Market has been evaluated as a growing market and it is expected that the market will touch high growth figures. The increasing prevalence of uterine fibroids and growing number of hysterectomy surgeries every year in this region are some of the factors driving the market for this disease. There are several other treatment options available now a days in U.S. that are driving the overall uterine fibroids market such as self-help techniques, pharmacotherapy, uterine artery embolization and invasive surgical procedures (myomectomy & hysterectomy). The U.S. Uterine Fibroids market is expected to reach USD 39,993.2 million in 2022.

Request a Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/2394

Competitive Analysis-

Major Key Players in Global Uterine Fibroid Market are:

The major participants of this market are AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.) and others.

Intended Audience

-Uterine Fibroid Devices and Drug Manufacturers
-Uterine Fibroid Devices and Drug Suppliers
-Private Research Laboratories
-Research and Development (R&D) Companies
-Market Research and Consulting Service Providers
-Medical Research Laboratories

Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 47 numbers of pages of the project report "Uterine Fibroid Market - U.S. Forecast to 2022"

Access Report Details @ https://www.marketresearchfuture.com/reports/uterine-fibroid-market-2394

Key Finding

The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.

By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.

By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.

Market Segmentation:

U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.